Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry.

[1]  John D. Carroll,et al.  Clinical outcomes at 1 year following transcatheter aortic valve replacement. , 2015, JAMA.

[2]  M. Mack,et al.  Insights from the early experience of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. , 2015, JACC. Cardiovascular interventions.

[3]  Tamara Syrek Jensen,et al.  Transcatheter valve therapy registry is a model for medical device innovation and surveillance. , 2015, Health affairs.

[4]  Sean M. O'Brien,et al.  The association of transcatheter aortic valve replacement availability and hospital aortic valve replacement volume and mortality in the United States. , 2014, The Annals of thoracic surgery.

[5]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[6]  Thoralf M Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[7]  P. Serruys,et al.  Transcatheter aortic valve replacement and vascular complications definitions. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[8]  J. Leipsic,et al.  Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[9]  Sean M. O'Brien,et al.  Outcomes following transcatheter aortic valve replacement in the United States. , 2013, JAMA.

[10]  L. Jordaens,et al.  Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic CoreValve System. , 2013, International journal of cardiology.

[11]  Danica Marinac-Dabic,et al.  The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. , 2013, Journal of the American College of Cardiology.

[12]  Danica Marinac-Dabic,et al.  The international registry infrastructure for cardiovascular device evaluation and surveillance. , 2013, JAMA.

[13]  J. Spertus,et al.  Use of the Kansas City Cardiomyopathy Questionnaire for Monitoring Health Status in Patients With Aortic Stenosis , 2013, Circulation. Heart failure.

[14]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.

[15]  J. Fajadet,et al.  Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[16]  M. Mack,et al.  Rational dispersion for the introduction of transcatheter valve therapy. , 2011, JAMA.

[17]  Pascal Vranckx,et al.  Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. , 2011, Journal of the American College of Cardiology.

[18]  G. Latsios,et al.  VALVULAR AND STRUCTURAL HEART DISEASES Original Studies ‘‘Device Landing Zone’’ Calcification, Assessed by MSCT, as a Predictive Factor for Pacemaker Implantation After TAVI , 2010 .

[19]  Gernot Brockmann,et al.  Predictors for new-onset complete heart block after transcatheter aortic valve implantation. , 2010, JACC. Cardiovascular interventions.

[20]  M. Mack,et al.  Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. , 2008, The Journal of thoracic and cardiovascular surgery.

[21]  J. Spertus,et al.  Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. , 2000, Journal of the American College of Cardiology.